Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study.
Ramonda R, Lorenzin M, Sole Chimenti M, D'Angelo S, Marchesoni A, Salvarani C, Lubrano E, Costa L, Dal Bosco Y, Fracassi E, Ortolan A, Ferraioli M, Carriero A, Visalli E, Bixio R, Desiati F, Bergamini A, Pedrollo E, Doria A, Foti R, Carletto A.
Ramonda R, et al. Among authors: carletto a.
Ther Adv Musculoskelet Dis. 2022 Apr 29;14:1759720X221090310. doi: 10.1177/1759720X221090310. eCollection 2022.
Ther Adv Musculoskelet Dis. 2022.
PMID: 35510168
Free PMC article.